Status of Anaplastic Lymphoma Kinase (ALK) in Malignant Mesothelioma

被引：0
|
作者：
Varesano, Serena [1 ]
Leo, Claudio [1 ]
Boccardo, Simona [1 ]
Salvi, Sandra [1 ]
Truini, Mauro [1 ]
Ferro, Paola [3 ]
Fedeli, Franco [3 ]
Canessa, Pier Aldo [4 ]
Dessanti, Paolo [3 ]
Pistillo, Maria Pia [2 ]
Roncella, Silvio [3 ]
机构：
[1] Natl Inst Canc Res, Div Histopathol & Cytopathol, Ist Ricovero & Cura Carattere Sci Azienda Osped U, Genoa, Italy
[2] Natl Inst Canc Res, Unit Tumor Epigenet, Ist Ricovero & Cura Carattere Sci Azienda Osped U, Genoa, Italy
[3] Azienda Sanit Locale 5, Div Histopathol & Cytopathol, La Spezia, Italy
[4] Azienda Sanit Locale 5, Div Pneumol, La Spezia, Italy
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 05期
关键词：
Anaplastic lymphoma kinase; crizotinib; fluorescent in situ hybridization; immunohistochemistry; malignant mesothelioma; targeted therapy; CELL LUNG-CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Malignant mesothelioma (MM) is a particularly aggressive type of primary tumor, associated with exposure to asbestos, and characterized by high mortality. To date, there is no curative therapy for MM. The receptor anaplastic lymphoma kinase (ALK) was found to be mutated in many cases of cancer and used as a target in biological therapies. We investigated whether this pharmacological treatment could also be applicable to MM. Materials and Methods: The state of ALK was analyzed by immunohistochemistry and fluorescent in situ hybridization in 63 MM tissue specimens. Results: None of the 63 MM samples showed overexpression or translocation of ALK. Conclusion: Our preliminary data exclude the utility of analysis of the ALK gene in MM and suggest that ALK inhibitor therapy is not applicable to MM.
引用
收藏
页码：2589 / 2592
页数：4
相关论文
共 50 条
  • [21] RESISTANCE TO ANAPLASTIC LYMPHOMA KINASE (ALK) TYROSINE KINASE INHIBITORS (TKIs) IN PAEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
    Hare, L.
    Prokoph, N.
    Burke, A.
    Turner, S.
    LEUKEMIA RESEARCH, 2022, 121 : S14 - S16
  • [22] A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
    Trinei, M
    Lanfrancone, L
    Campo, E
    Pulford, K
    Mason, DY
    Pelicci, PG
    Falini, B
    CANCER RESEARCH, 2000, 60 (04) : 793 - 798
  • [23] Expression of anaplastic lymphoma kinase (ALK) protein in pediatric tumors
    Debelenko, LV
    Romero, M
    Tsokos, M
    MODERN PATHOLOGY, 2003, 16 (01) : 301A - 301A
  • [24] Anaplastic lymphoma kinase (ALK) mutations in patients with adenocarcinoma of the lung
    Mohamad, N.
    Jayalakshmi, P.
    Rhodes, A.
    Liam, C-K
    Tan, J-L
    Yousoof, S.
    Rajadurai, P.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2017, 74 (04) : 176 - 180
  • [25] Expression of anaplastic lymphoma kinase (ALK) in merkel cell carcinomas
    Filtenborg-Barnkob, B. E.
    Bzorek, M.
    APMIS, 2013, 121 : 17 - 17
  • [26] Anaplastic Lymphoma Kinase (ALK) Gene Aberrations in Breast Cancers
    Hanna, M. G.
    Najfeld, V.
    Tripodi, J.
    Hanna, I. Y.
    Nayak, A.
    MODERN PATHOLOGY, 2014, 27 : 52A - 52A
  • [27] Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain
    Lee, Christian C.
    Jia, Yong
    Li, Nanxin
    Sun, Xiuying
    Ng, Kenneth
    Ambing, Eileen
    Gao, Mu-Yun
    Hua, Su
    Chen, Connie
    Kim, Sungjoon
    Michellys, Pierre-Yves
    Lesley, Scott A.
    Harris, Jennifer L.
    Spraggon, Glen
    BIOCHEMICAL JOURNAL, 2010, 430 : 425 - 437
  • [28] ALK IDENTIFICATION (ANAPLASTIC LYMPHOMA KINASE) AS A GENE SUSCEPTIBLE TO NEUROBLASTOMA
    Mosse, Y. P.
    Laudenslager, M.
    Longo, L.
    Cole, K. A.
    Wood, A.
    Attiyeh, E. F.
    Laquaglia, M. J.
    Sennett, R.
    Lynch, J. E.
    Perri, P.
    Laureys, G.
    Speleman, F.
    Hakonarson, H.
    Torkamani, A.
    Schork, N. J.
    Brodeur, G. M.
    Tonini, G. P.
    Rappaport, E.
    Devoto, M.
    Maris, J. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S3 - S4
  • [29] Expression of anaplastic lymphoma kinase (ALK) protein in pediatric tumors
    Debelenko, LV
    Romero, M
    Tsokos, M
    LABORATORY INVESTIGATION, 2003, 83 (01) : 301A - 301A
  • [30] Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery
    Wang, Wen-Chieh
    Shiao, Hui-Yi
    Lee, Chieh-Chien
    Fung, Ka-Shu
    Hsieh, Hsing-Pang
    MEDCHEMCOMM, 2014, 5 (09) : 1266 - 1279
12345